Sudden Cardiac Death in Adult Congenital Heart Disease

Area of Science:

• Cardiology
• Adult Congenital Heart Disease
• Electrophysiology

Background:

• Sudden arrhythmic death is a leading cause of mortality in adults with congenital heart disease.
• Implantable cardioverter-defibrillators (ICDs) offer potential benefits but carry significant complication risks.
• Lack of robust randomized trial data complicates clinical decision-making for ICD implantation.

Purpose of the Study:

• To review risk stratification strategies for primary prevention ICDs in adults with congenital heart disease.
• To identify factors associated with sudden death in specific congenital heart disease populations.
• To highlight controversies in risk assessment for certain complex congenital heart conditions.

Main Methods:

• Literature review of studies on sudden death and ICDs in adults with congenital heart disease.
• Analysis of risk factors for sudden death in tetralogy of Fallot.
• Examination of challenges in risk stratification for systemic right ventricles and univentricular hearts.

Main Results:

• Risk factors for sudden death in tetralogy of Fallot are relatively consistent across studies.
• Identifying high-risk patients with systemic right ventricles or univentricular hearts for ICDs remains controversial.
• Evidence supporting primary prevention ICDs in many adult congenital heart disease populations is limited.

Conclusions:

• Careful consideration of benefits versus complications is essential when deciding on ICDs for adults with congenital heart disease.
• Further research, including randomized trials, is needed to guide primary prevention ICD implantation.
• Risk stratification remains challenging, particularly for complex congenital heart anatomies.